Our data fit the model that additional TSC2 mutations occur in small clonal populations of dermal fibroblasts that are undergoing clonal expansion but are not recognized clinically; these clonal populations represent a tumor that we call a micro-FAF. This evidence concerns the gene TSC2 and neoplasm.